• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Chemotherapeutic combinations of mutually potentializing drugs. 1-Application to the treatment of breast cancers].

作者信息

Pouillart P, Schwarzenberg L, Amiel J L, Mathé G, Huguenin P, Morin P, Baron A, Laparre Ch, Parrot R

出版信息

Nouv Presse Med. 1975 Mar 8;4(10):713-6.

PMID:1129034
Abstract

27 patients suffering from disseminated carcinoma of the breast with at least two visceral metastases, and two had become resistant to conventional chemotherpy and hormones, received a combination of, in the present trial, vincristine followed by cyclophosphamide with 5-fluoro-uracil. Chemotherapy was administered intermittently: each cycle of treatment lasted 6 days and was followed by a period without treatment of 25 days. Haematological tolerance was satisfactory. No serious incidents occurred during two years use of the combination. 20 out of 27 patients showed objective tumour regression of more than 50 p.cent lasting for more than 6 months, whilst 9 showed apparent complete regression of the malignant lesions. There was one complete failure. Chemotherapy was continued in all cases after regression of the neoplastic process was obtained.

摘要

相似文献

1
[Chemotherapeutic combinations of mutually potentializing drugs. 1-Application to the treatment of breast cancers].
Nouv Presse Med. 1975 Mar 8;4(10):713-6.
2
[Chemotherapeutic combinations of mutually potentiating drugs. 2-Application to the treatment of bronchial cancers].[相互增效药物的化疗联合方案。2. 应用于支气管癌的治疗]
Nouv Presse Med. 1975 Mar 8;4(10):717-9.
3
[Chemotherapeutic combinations of mutually potentiating drugs. 3-Application to primary tumors of the central nervous system].[相互增效药物的化疗联合方案。3. 应用于中枢神经系统原发性肿瘤]
Nouv Presse Med. 1975 Mar 8;4(10):721-4.
4
Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.环磷酰胺、甲氨蝶呤、5-氟尿嘧啶、长春新碱和泼尼松辅助化疗与单药左旋苯丙氨酸氮芥治疗可手术乳腺癌且腋窝淋巴结阳性患者的比较:西南肿瘤协作组20年研究结果
Cancer. 2003 Jan 1;97(1):21-9. doi: 10.1002/cncr.10982.
5
Combination chemotherapy for disseminated carcinoma of the breast.
Bol Asoc Med P R. 1975 Jun;67(6):157-63.
6
Multidisciplinary curative treatment for disseminated carcinoma of the breast.乳腺癌播散的多学科治愈性治疗
Cancer Treat Rep. 1976 Jan;60(1):85-9.
7
[Control studies on the cytostatic combination therapy in metastasizing breast carcinoma].
Internist (Berl). 1973 Dec;14(12):643-52.
8
Chemotherapy in the treatment of malignant brain tumors.
Adv Neurol. 1975;13:149-191.
9
Combination chemotherapy for advanced mammary carcinoma: a twelve-year experience.
Mt Sinai J Med. 1972 Sep-Oct;39(5):435-46.
10
[Cytostatic combination therapy in metastatic breast cancer].
Ugeskr Laeger. 1973 Jun 18;135(25):1336-40.